Krystal Biotech, Inc. (KRYS) Covered Calls

You can sell covered calls on Krystal Biotech, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for KRYS (prices last updated Fri 4:16 PM ET):

Krystal Biotech, Inc. (KRYS) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
39.81 -2.63 25.88 50.69 250K - 0.9
Covered Calls For Krystal Biotech, Inc. (KRYS)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Dec 17 40 13.00 37.69 6.1% 101%
Jan 21 40 12.60 38.09 5.0% 32.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Krystal Biotech, Inc., a gene therapy company, develops and commercializes medicines for patients suffering from skin diseases in the United States. The company's lead product candidate is beremagene geperpavec (B-VEC), which has completed Phase I/II clinical study to treat dystrophic epidermolysis bullosa. It is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive congenital ichthyosis; KB301, which is in preclinical stage for treating aesthetic skin conditions; KB104 that is in preclinical stage for the treatment of Netherton Syndrome; and KB5xx for treating chronic skin diseases, which is in discovery stage. The company was formerly known as Krystal Biotech, LLC and changed its name to Krystal Biotech, Inc. in March 2017. Krystal Biotech, Inc. was founded in 2015 and is headquartered in Pittsburgh, Pennsylvania.